XML 44 R26.htm IDEA: XBRL DOCUMENT v3.21.1
Organization and Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2020
Reconciliation of Numerators and Denominators used in Computing Basic and Diluted Net Income Per Share
The following is a reconciliation of the numerators and denominators used in computing basic and diluted net income per share:
 
   
12 Month

Period Ended

December 31,

2020
  
12 Month

Period Ended

December 31,

2019
  
12 Month

Period Ended

December 31,

2018
 
Net loss
  $(14,812,156 $(10,439,961 $(5,172,436
   
 
 
  
 
 
  
 
 
 
Numerator, basic and diluted net loss available to stockholders
  $(14,812,156 $(10,439,961 $(5,172,436
   
 
 
  
 
 
  
 
 
 
    
Denominator:
             
Shares used in computation – basic:
             
Weighted average common shares outstanding
   10,538,114   9,346,213   8,583,795 
   
 
 
  
 
 
  
 
 
 
Shares used in computation – diluted:
             
Weighted average common shares outstanding
   10,538,114   9,346,213   8,583,795 
   
 
 
  
 
 
  
 
 
 
Net loss per share – basic and diluted
  $ (1.41)  $ (1.12)  $ (0.60) 
   
 
 
  
 
 
  
 
 
 
Schedule of Financial Instruments at Fair Value on a Recurring Basis
We measure certain financial instruments at fair value on a recurring basis. The Company had liabilities that are required to be measured at fair value on a recurring basis as follows at December 31, 2020.
 
   
Total
   
Level 1
   
Level 2
   
Level 3
 
Assets:
  $—     $—     $—     $—   
Liabilities:
                    
Hybrid debt instrument at fair value
  $—     $—     $—     $—   
Reconciliation of the Beginning and Ending Balances for the Liability Measured at Fair Value on a Recurring Basis
The following is a reconciliation of the beginning and ending balances for the liability measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the year December 31, 2020: See footnote NOTE H: Note 10 – 37North for further detail.
 
Balance at December 31, 2019
  $861,484 
Additional debt issuances
   490,000 
Conversion to equity
   (2,084,442
Loss on change in derivative liability
   732,958 
   
 
 
 
Balance at December 31, 2020
  $—   
   
 
 
 
Convertible Preferred Stock Excluded from EPS [Member]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The equivalent common shares relating to our unvested restricted stock awards that were excluded from potential common shares used in the earning per share calculation due to having an anti-dilutive effect are:
 
   
2020
   
2019
   
2018
 
Excluded unvested restricted stock awards
   249,391    41,667    41,667 
In the Money Potential Common Shares [Member]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The potential common shares, in the table following, represent potential common shares calculated using the treasury stock method from outstanding options and warrants that were excluded from the calculation of Diluted EPS:
 
   
2020
   
2019
   
2018
 
Average market price during the period
  $5.06   $4.93   $6.81 
In the money potential common shares from options excluded
   22,493    22,493    13,450 
In the money potential common shares from warrants excluded
   2,585,179    120,000    50,640 
Out of Money Potential Common Shares [Member]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Potential common shares from
out-of-the-money
options and warrants were also excluded from the computation of diluted earnings per share because calculation of the associated potential common shares has an anti-dilutive effect. The following table lists options and warrants that were excluded from diluted EPS.
 
Per share
exercise price
  
2020
   
2019
   
2018
 
Out of the money options excluded:
 
          
$12.48
   136,833    136,833    136,833 
$12.84
   4,167    4,167    4,167 
$26.40
   75,158    75,158    75,158 
Out-of-the-money
warrants excluded:
 
          
$5.76
   196,135    196,135    —   
$7.16
   700,000    700,000    700,000 
$12.00
   —      —      65,625 
   
 
 
   
 
 
   
 
 
 
Total excluded
   1,112,293    1,112,293    981,783